The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates.  A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading ->
Canada has lost its measles elimination status after 12 months of continuous transmission of the highly infectious disease, the Pan-American Health Organization (PAHO) announced on Monday. This follows a PAHO expert meeting on infectious diseases last week, the Measles, Rubella, and Congenital Rubella Syndrome Elimination Regional Monitoring and Re-Verification Commission. “The commission determined that endemic […] Continue reading ->
Season 5 of the Global Health Matters podcast opens with a blunt diagnosis of the field’s future from two leading voices, and a roadmap for reform. In a conversation with host Garry Aslanyan, Paola Abril Campos Rivera of Tecnológico de Monterrey and Catherine Kyobutungi, head of Kenya’s African Population and Health Research Centre, argue that […] Continue reading ->
At least $7 billion is needed to rebuild Gaza’s health system, which has no fully functioning hospitals, and critical shortages of essential medicines, equipment and health workers, World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyesus told a media briefing on Thursday. While Tedros welcomed the ceasefire negotiated by US President Donald Trump on […] Continue reading ->
There is an urgent need for a more comprehensive pandemic risk monitoring system that tracks threats and preparedness in real time, according to the WHO-hosted Global Preparedness Monitoring Board, in a report launched at the World Health Summit. This followed the release of a new World Health Organization data documenting the sharp global rise in […] Continue reading ->